Account

A comprehensive overview of Ipamorelin, a peptide that stimulates the release of growth hormone (GH)
through selective activation of ghrelin receptors.
This section details the clinical background and therapeutic potential of the compound,
highlighting its role as the first truly selective GH secretagogue.

Save citation to file

To facilitate academic referencing, this article can be exported in BibTeX or En

Peptide Therapy: CJC-1295 + Ipamorelin

CJC‑1295 is a synthetic growth hormone‑releasing hormone analogue that stimulates the pituitary
gland to produce more natural growth hormone (GH). Ipamorelin, on the other hand, is a selective ghrelin receptor
agonist that specifically triggers GH release without affecting
cortisol or prolactin levels. When combined, these two peptides
create a synergist

Start your online visit

Begin by exploring the differences between Ipamorelin and Sermorelin, two
popular growth hormone‑releasing peptides used
to enhance overall health and vitality.

Erectile Dysfunction

While neither peptide directly treats erectile dysfunction (ED), improved hormonal
balance can support vascular function and libido, indirectly benefiting sexual performance.

Discuss how healthy hormone levels contribute to erectile funct

Understanding Different Ipamorelin CJC 1295 Dosages

Ipamorelin and CJC‑1295 are two of the most popular growth hormone secretagogues (GHS) used in both clinical research and wellness communities.
While each peptide has its own unique pharmacokinetic profile,
they are often paired because their mechanisms complement one another:
Ipamorelin is a selective ghrelin receptor agonist that
stimulates growth hormone release with m